Shilajit and Thyroid Support After Menopause

What menopause does to thyroid function

The thyroid does not work in isolation. Estrogen and progesterone both interact with thyroid hormone binding proteins and receptors throughout the body. When those hormones fall after menopause, the thyroid often has to work harder to deliver the same signal. The result is that subclinical hypothyroidism, where TSH is elevated but T4 still reads normal, becomes significantly more common in postmenopausal women than in women who are still cycling.

Fatigue, weight resistance, brain fog, and hair thinning are where the two systems overlap. The symptoms are similar enough that many women assume they are dealing with menopause alone, when sometimes the thyroid is quietly struggling alongside it.

This is not a problem shilajit fixes directly. It is context for why the thyroid's mineral needs deserve attention at this stage, and why what you are taking to support mineral supply actually matters. For more on why mineral form and delivery determine what actually reaches your cells, see our post on whole-food minerals vs. isolated vitamins.

The mineral supply chain behind every thyroid hormone

Making thyroid hormone is a manufacturing process. The raw materials have to arrive in the right form at the right place.

Iodine is the structural backbone. T3 has three iodine atoms. T4 has four. Without adequate iodine, the thyroid cannot build either form.

Selenium powers the conversion step. Most thyroid hormone leaves the gland as T4, the storage form. To become active T3, it has to be converted by an enzyme family called deiodinases. Those enzymes are selenium-dependent. Low selenium means slow, incomplete conversion, and that is where much of the functional thyroid underperformance in older women actually happens. Not at production. At activation.

Zinc supports the pituitary-thyroid signaling axis and plays a direct role in the conversion enzymes alongside selenium. Low zinc quietly degrades both the production signal and the activation step at once.

Magnesium is involved in multiple enzyme pathways throughout thyroid hormone metabolism. Low magnesium quietly slows the whole system.

None of these minerals is made by the body. They all come in through food and supplementation, or they do not come in at all.

Where shilajit fits into this picture

Shilajit from the Altai mountains is a compressed, fossilized organic resin that forms over centuries as plant matter and microbial metabolites break down under geological pressure. A 2007 review by Agarwal et al. (PMID 17295385) documented shilajit's mineral profile. It includes selenium, iodine, zinc, magnesium, iron, copper, and over 80 additional trace elements in the form of fulvic acid complexes.

The key word is complexed. Fulvic acid is a naturally occurring short-chain organic acid that wraps around mineral ions and carries them across biological membranes with unusual efficiency. A 2018 review by Winkler and Ghosh (PMC6151376) described fulvic acid's role as an electron transporter and mineral chelator that improves cellular uptake of the minerals it binds. For a deeper look at the carrier mechanism itself, see our fulvic acid explainer.

That difference in delivery form matters. Isolated minerals in standard supplement form have to be broken down, re-complexed by digestive acids, and shuttled across gut lining cells through specialized carrier proteins. Fulvic-acid-bound minerals may bypass some of those steps. The absorption pathway is not identical to a synthetic chelate, but the bottleneck is substantially reduced.

This is the honest case for shilajit and thyroid support. Shilajit does not stimulate the thyroid or adjust TSH directly. What it does is deliver the mineral ingredients the thyroid is always consuming, in a form that may arrive more intact and be more readily used.

What the animal research suggests

Shilajit-specific thyroid research is limited. There is one directly relevant animal study worth noting. Vucskits et al. (2010) tested fulvic and humic acids on several health parameters in rats, including thyroid function markers (PMID 21073632). The study found measurable effects on thyroid-related measures in the animals receiving fulvic and humic supplementation.

That is animal data, not human trial data. It tells us the active compounds in shilajit interact with thyroid biology at the dosages tested. It does not tell us the effect size in a postmenopausal woman with subclinical hypothyroidism. The researchers drew no treatment conclusion, and neither does this post.

What the study does is corroborate that fulvic and humic acids, the active fraction of shilajit, are not inert as far as thyroid biology is concerned. That is meaningful context. It is not a prescription.

A separate 2017 rat study by Szabó et al. (PMID 28244332) examined how fulvic and humic acids affect iron and manganese homeostasis, documenting that these compounds measurably alter how the body handles key trace minerals. Since thyroid enzyme function depends on trace mineral availability, these mineral-regulation effects are part of the same story.

Safety, estrogen, and the honest evidence ceiling

Shilajit is not a hormone. It does not directly raise estrogen or introduce thyroid hormones. What it does is support the body's own estrogen signaling through its fulvic acid and mineral content, which is a different mechanism entirely from hormone replacement.

A 2014 safety review (PMID 23733436) found shilajit to be generally well tolerated across the human and animal studies examined, with zero serious adverse events reported across any human shilajit trial. Our purified shilajit from the Altai mountains is independently third-party lab tested for heavy metals, mold, and mycotoxins. The full safety evidence is reviewed in our shilajit safety overview.

For women who carry concern about estrogen and cancer, a cell study (PMID 27177083) found that fulvic acid triggered death in MCF-7 estrogen-receptor-positive breast cancer cells while leaving healthy cells unaffected. That is in-vitro data, not clinical proof, but it speaks to the most common concern directly.

The honest evidence ceiling for shilajit and thyroid support is this. No human trial has proven that shilajit improves thyroid hormone levels in postmenopausal women. What exists is a documented mechanism for why selenium, iodine, zinc, and magnesium are essential to thyroid function, solid evidence that shilajit delivers all four in fulvic-complexed form, and an animal study confirming that shilajit's active compounds are biologically active in thyroid tissue.

What this means for you

If your thyroid is functioning normally, shilajit's mineral profile supports the supply chain it already depends on. If your TSH is trending up and your provider is watching but not yet treating, you are in the window where mineral sufficiency is most likely to matter. If you are already on thyroid medication, adding minerals is not a substitute for that medication, but the supply chain still needs to run.

The summary is straightforward. Shilajit from the Altai mountains reliably delivers selenium, iodine, zinc, and magnesium alongside its 80+ other trace minerals in a form that fulvic acid makes more bioavailable than most supplement forms. What it offers is not thyroid treatment. It is mineral nutrition, done more completely than most people manage from food alone.

References

1. Agarwal SP et al. (PMID 17295385). Review of shilajit composition including fulvic acid fraction and trace mineral profile. https://pubmed.ncbi.nlm.nih.gov/17295385/
2. Winkler J and Ghosh S (PMC6151376). "Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes." Review of fulvic acid as mineral chelator and electron transporter. https://pmc.ncbi.nlm.nih.gov/articles/PMC6151376/
3. Vucskits AV et al. (PMID 21073632). "Effect of fulvic and humic acids on performance, immune response and thyroid function in rats." Animal study documenting thyroid function effects. https://pubmed.ncbi.nlm.nih.gov/21073632/
4. Szabó et al. (PMID 28244332). "Effect of fulvic and humic acids on iron and manganese homeostasis in rats." Animal study on fulvic/humic trace mineral regulation. https://pubmed.ncbi.nlm.nih.gov/28244332/
5. Stohs SJ et al. (PMID 23733436). Safety and efficacy review of shilajit across human and animal studies; zero serious adverse events reported. https://pubmed.ncbi.nlm.nih.gov/23733436/
6. (PMID 27177083). Fulvic acid triggered cell death in MCF-7 estrogen-receptor-positive breast cancer cells while sparing healthy cells. https://pubmed.ncbi.nlm.nih.gov/27177083/